Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis;Czynnik martwicy nowotworu (TNF) i interleukina-6 (IL-6) w kłebuszkowych zapaleniach nerek

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 3, 1996, Pages 224-233

  Kacprzyk, Feliks ^a   Chrzanowski, Witold ^a  

^a Klini Nefrologiczna IMW Akademii M

Author keywords

Cytokines; Glomerulonephritis; Interleukin 6; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; FEMALE; GLOMERULONEPHRITIS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030224483     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Al-Janadi M., Al-Balla S., Al-Dalaan A., Raziuddin S.: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol., 1993, 13, 58.
2. Border W.A., Okuda S., Languino L.R., Sporn M.B., Ruoslahti E.: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-beta, Nature, 1990, 346, 371.
3. Dohi K., Iwano M., Muraguchi A. i wsp.: The prognostic significance of urinary interleukin 6 in IgA nephropathy. Clin. Nephrol., 1991, 35, 1.
4. Feldmann M., Brennan F.M., Chantry D., Howarth C. i wsp.: Cytokine assays: Role in the evaluation of the pathogenesis of autoimmunity. Immunol. Rev., 1991, 119, 105.
5. Fukatsu A., Matsuo S., Tamai H., Sakamoto N., Matsuda T., Hirano T.: Distribution of interleukin-6 normal and diseased human kidney. Lab. Invest., 1991, 65, 61.
6. Hancock W.W., Thomson N.M., Atkins R.C.: Monoclonal antibody analysis of interstitial cell infiltrate during human renal allograft rejection. Transpl. Proc., 1983, 15, 352.
7. Hirano T., Yasukawa K., Harada H. i wsp.: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 1986, 324, 73.
8. Horii Y., Muragucci A., Iwano M.: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol., 1989, 143, 3949.
9. Iwano M., Dohi K., Hirata E.: Urinary levels of IL-6 in patients with active lupus nephritis. Clin. Nephrol., 1993, 40, 16.
10. Levin M., Smith C., Walters M.D.S., Gascoine P.: Steroid-responsive nephrotic syndrome: a generalized disorder of membrane negative charge. The Lancet, 1985, 2, 239.
11. Matsumoto K.: Increased release of tumor necrosis factor-alfa by monocytes from patients with glomerulonephritis. Clin. Nephrol., 1993, 40, 148.
12. Montinaro V., Hevey K., Aventaggiato L.: Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int., 1992, 42, 341.
13. Noronha I.L., Weis H., Rambausek M., Ritz E., Waldherr R.: Expression of IL-1β, PDGF, TGF-β1 + β2, TGF-β3 and IFN-γ receptor (IFN-γR) in IgA-glomerulonephritis (IgA-GN) and in acute renal allograft rejection. J. Am. Soc. Nephrol., 1991, 2, 602 (abstract).
14. Otha K., Takano N., Seno A. i wsp.: Detection and clinical usefulness of urinary interleukin-6 in the disease of the kidney and the urine tract. Clin. Nephrol., 1992, 38, 185.
15. Ozen S., Saatci U., Tinaztepe K., Bakkaloglu A., Barut A.: Urinary tumor necrosis factor levels in primary glomerulopathies. Nephron, 1994, 66, 291.
16. Suranyi M.G., Guasch A., Hall B.M., Myers B.D.: Elevated levels o tumor necrosis factor-alfa in the nephrotic syndrome in humans. Am. J. Kidney Dis., 1993, 21, 251.
17. Tipping P.G., Leong T. W., Holdsworth S.R.: Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab. Invest., 1991, 65, 272.
18. Tomino Y., Funabiki K., Ohmuro H. i wsp.: Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy. Am. J. Nephrol., 1991, 11, 459.
19. Tomosugi N.I., Cashman S.J., Hay H. i wsp.: Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J. Immunol., 1989, 142, 3083.
20. Yoshioka K., Takemura T., Murakami K.: In situ expression of cytokines in IgA nephritis. Kidney Int., 1993, 44, 825.